Bioxcel Therapeutics Inc
Clinical trials sponsored by Bioxcel Therapeutics Inc, explained in plain language.
Biopharmaceutical company developing therapies for neuropsychiatric and neurological disorders using artificial intelligence.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a pill rouse the immune system against pancreatic cancer?
Disease control TerminatedThis early-phase trial is testing whether an experimental oral drug called BXCL701 can change how the immune system responds to pancreatic cancer. The study will enroll people with untreated, locally advanced or metastatic pancreatic cancer who can undergo tumor biopsies before a…
Phase: EARLY_PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a dissolvable film quiet ICU delirium?
Symptom relief TerminatedThis phase 2 trial is testing whether a dissolvable film containing dexmedetomidine (BXCL501) can safely and effectively reduce agitation in adult ICU patients who have delirium. The study will compare four different starting doses of the drug against a placebo to find the best b…
Phase: PHASE2 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC